AdamBurgoyneMDPhD(He/Him)

Summary

• Adam Burgoyne, MD, PhD, is a medical oncologist with research and clinical interests in gastrointestinal and hepatobiliary oncology at UC San Diego. His clinical practice at the Moores Cancer Center is primarily dedicated to the care of patients with hepatocellular carcinoma (HCC), where he co-leads a multidisciplinary primary liver cancer clinic and serves as the principal investigator of both sponsored and investigator-initiated clinical trials for patients with advanced liver cancer. As an academic physician-scientist, he also runs a basic and translational science laboratory working on the development and validation of a cellular state prediction model of sensitivity and resistance to targeted therapies in HCC. Dr. Burgoyne earned his medical degree and doctorate from Case Western Reserve University School of Medicine in Cleveland, Ohio. He completed his residency in internal medicine, fellowship in hematology/oncology, and post-doctoral research training at UC San Diego. He joined the faculty within the Division of Hematology/Oncology at UC San Diego in February 2017, where he is currently an Assistant Clinical Professor.